|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,966.00 GBX | -0.68% |
|
+2.56% | +8.50% |
| 02:11pm | Oil keeps markets on edge |  |
| 01:28pm | UK stocks-factors to watch on July 9 | RE |
| Market Cap | 78.88B 105B 92.45B 85.36B 150B 10,093B 152B 1,026B 399B 4,939B 396B 387B 17,146B | P/E 2026 * |
12.7x | P/E 2027 * | 11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 94.31B 126B 111B 102B 179B 12,068B 182B 1,227B 477B 5,905B 473B 463B 20,500B | EV / Sales 2026 * |
2.78x | EV / Sales 2027 * | 2.56x |
| Free-Float |
92.29% | Yield 2026 * |
3.52% | Yield 2027 * | 3.71% |
Last Transcript: GSK plc
| 1 day | -0.66% | ||
| 1 week | +2.56% | ||
| Current month | -0.08% | ||
| 1 month | +3.48% | ||
| 3 months | -6.85% | ||
| 6 months | +4.68% | ||
| Current year | +8.50% |
| 1 week | 1,964 |  | 2,049 |
| 1 month | 1,890.5 | | 2,049 |
| Current year | 1,690 | | 2,282 |
| 1 year | 1,288.6 | | 2,282 |
| 3 years | 1,242.5 | | 2,282 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 01/01/2026 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 01/05/2023 |
| Chief Tech/Sci/R&D Officer | - | 01/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | - | 06/05/2026 |
Hal Barron
BRD | Director/Board Member | 64 | 01/01/2018 |
Jonathan Symonds
CHM | Chairman | 68 | 01/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-22 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 06-08 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 05-22 | Buy | Executive/Senior Manager | 9 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.68% | +2.56% | +39.99% | +50.42% | 105B | |
| -1.60% | +2.02% | +56.34% | +168.94% | 1,084B | |
| -1.44% | +3.71% | +69.07% | +65.40% | 634B | |
| -0.75% | +0.67% | +33.18% | +86.52% | 447B | |
| -0.21% | +1.86% | +29.96% | +26.28% | 330B | |
| -0.86% | +2.79% | +37.72% | +40.85% | 295B | |
| -0.21% | +0.72% | +28.85% | +48.27% | 285B | |
| -0.63% | -0.26% | -28.18% | -39.82% | 218B | |
| -0.03% | +1.84% | +23.90% | +68.30% | 199B | |
| -0.40% | +7.82% | +22.29% | +82.50% | 169B | |
| Average | -0.85% | +2.52% | +31.31% | +59.77% | 376.53B | |
| Weighted average by Cap. | -1.11% | +2.48% | +41.30% | +85.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.86B 45.26B 39.69B 36.65B 64.19B 4,333B 65.47B 441B 171B 2,121B 170B 166B 7,361B | 35.59B 47.56B 41.72B 38.51B 67.46B 4,554B 68.81B 463B 180B 2,229B 179B 175B 7,737B |
| Net income | 6.47B 8.65B 7.59B 7.01B 12.27B 828B 12.52B 84.21B 32.72B 405B 32.49B 31.77B 1,407B | 6.94B 9.27B 8.13B 7.51B 13.15B 888B 13.41B 90.27B 35.07B 434B 34.82B 34.06B 1,508B |
| Net Debt | 15.43B 20.62B 18.09B 16.7B 29.25B 1,975B 29.83B 201B 78B 966B 77.44B 75.74B 3,354B | 12.24B 16.35B 14.34B 13.24B 23.19B 1,566B 23.66B 159B 61.85B 766B 61.41B 60.06B 2,660B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/07/26 | GBX 1,979.50 | -1.17% | 3,794,960 |
| 07/07/26 | GBX 2,003.00 | +1.01% | 4,183,855 |
| 06/07/26 | GBX 1,983.00 | -1.59% | 15,158,597 |
| 03/07/26 | GBX 2,015.00 | +0.55% | 2,548,759 |
| 02/07/26 | GBX 2,004.00 | +3.83% | 17,567,408 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
